Orion Infusion Limited announced unaudited earnings results for the second quarter and six months ended December, 2017. For the quarter, the company's EPS was BDT 0.42 against BDT 0.32 a year ago. For the six months, the company's EPS was BDT 0.79 against BDT 0.68 a year ago. NOCFPS was BDT 0.33 against BDT 0.34 a year ago. NAV per share was BDT 11.96 as on December 31, 2017 and BDT 12.57 as on June 30, 2017.